The role of Tau protein in resistance to paclitaxel (Q37895519)

24 August 2017

5 references

7 November 2019

11 December 2019

19 December 2019

26 October 2020

25 January 2021

The role of Tau protein in resistance to paclitaxel (English)

1 reference

24 August 2017

1 reference

7 November 2019

cytoskeletal proteins

1 reference

11 December 2019

nerve tissue proteins

1 reference

antineoplastic resistance

19 December 2019

1 reference

phytogenic antineoplastic agents

26 October 2020

1 reference

25 January 2021

6

Cezary Szczylik

1 reference

24 August 2017

2

Lubomir Bodnar

1 reference

24 August 2017

1

Marta Smoter

1 reference

24 August 2017

3

Renata Duchnowska

1 reference

24 August 2017

4

Rafał Stec

1 reference

24 August 2017

Bartłomiej Grala

5

1 reference

24 August 2017

29 June 2011

1 reference

PMCID

3162141

Cancer Chemotherapy and Pharmacology

24 August 2017

1 September 2011

5 references

7 November 2019

11 December 2019

19 December 2019

26 October 2020

25 January 2021

6 references

24 August 2017

7 November 2019

11 December 2019

19 December 2019

26 October 2020

25 January 2021

68

1 reference

24 August 2017

3

1 reference

24 August 2017

553-557

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-011-1696-7

24 August 2017

0 references

cites work

Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Repeat motifs of tau bind to the insides of microtubules in the absence of taxol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Structural insight into microtubule function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

The role of beta-tubulin isotypes in resistance to antimitotic drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

How Taxol stabilises microtubule structure.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

A protein factor essential for microtubule assembly

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162141

Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-011-1696-7

Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-011-1696-7

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

21 January 2018

1 reference

12 December 2020

Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau

1 reference

12 December 2020

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

12 December 2020

Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer

1 reference

12 December 2020

Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site

1 reference

12 December 2020

Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site

1 reference

12 December 2020

Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer

1 reference

12 December 2020

10.1007/S00280-011-1696-7

Identifiers

DOI

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

PMCID

3162141